Industry Explorers Blaze On

  1. Which CDMO Traits Predict Sponsor Loyalty When Outsourcing Small Molecule API? 8/1/2023

    Using data from Industry Standard Research’s Small Molecule API CDMO Benchmarking report, ISR ran a regression analysis to identify which contract manufacturer characteristics are most-closely related to sponsor loyalty.

  2. Vincerx Pharma: Finding Strength In Symbiosis 8/1/2023

    Ahmed Hamdy and Raquel Izumi are putting the lessons, hard knocks, and experiential wisdom they have gained over a decade in biotech to work at Vincerx.

  3. State Scrutiny Of Drug Pricing Intensifies With Rise Of PDABs 8/1/2023

    More than five years after state price transparency laws began spreading throughout the country, states have opened up a new front in their battle against what they deem to be excessively high prescription drug prices through the establishment of prescription drug affordability boards (PDABs).

  4. Should My Startup Buy Or Produce The Proteins We Use? 8/1/2023

    David Bienvenue, Ph.D., director of protein science AT Bonum Therapeutics, discusses his company’s challenge of deciding if they should build out a protein group or rely on vendors.

  5. Staff Burnout — A Threat To Clinical Operations Output 8/1/2023

    There are several measures that pharma companies and CROs can take to mitigate the issue of staff burnout.

  6. How To Be A Leader Employees Don't Leave 8/1/2023

    Being a leader who people want to stick with requires you to create a compelling vision of where you are going and taking your team — and you need to be able to communicate all of that in the same compelling manner.

  7. Why ERGs Are Critical To A Company's Future Success 8/1/2023

    There’s a common misconception that employee resource groups (ERGs) are purely social clubs — a view that completely misses the potential for these groups to drive business innovation, strategy, and talent development.

  8. 3 Lessons For Building Biostatistics++ Teams In Pharma 8/1/2023

    Based on my experience of more than two decades building biostatistics++ teams for Big Pharma, small biotech, and nonprofits, I offer the following advice for those interested in a path to business leadership and becoming a partner in drug development.

  9. Where Has All The Talent Gone In The U.K.? 8/1/2023

    Plugging and reversing the skills gap — to keep expertise in the U.K. and attract it from abroad — requires a strategic effort involving companies, investors, government, universities and other stakeholders.

  10. The Immigrant Approach To Biotech Formation 8/1/2023

    Flagship Pioneering General Partner Avak Kahvejian, Ph.D., says successfully ideating new biotech companies — which Flagship has done in spades — requires the curiosity, skepticism, and paranoia of a new inhabitant in foreign land. Oh, and a little bit of machine learning won’t hurt.